Vaccines that protect against severe illness, death and lingering long COVID-19 symptoms from a SARS-CoV-2 infection were linked to small increases in neurological, blood and heart-related conditions in the largest global vaccine safety study to date.
The rare events — identified early in the pandemic — included a higher risk of heart-related inflammation from mRNA shots made by Pfizer Inc, BioNTech SE and Moderna Inc, and an increased risk of a type of blood clot in the brain after immunization with viral-vector vaccines such as the one developed by the University of Oxford and made by AstraZeneca PLC.
The viral-vector jabs were also tied to an increased risk of Guillain-Barre syndrome, a neurological disorder in which the immune system mistakenly attacks the peripheral nervous system.
Photo: AP
More than 13.5 billion doses of COVID-19 vaccines have been administered globally over the past three years, saving more than 1 million lives in Europe alone. Still, a small proportion of people immunized were injured by the shots, stoking debate about their benefits versus harms.
The new research, by the Global Vaccine Data Network, was published in the journal Vaccine last week, with the data made available via interactive dashboards to show methodology and specific findings.
The research looked for 13 medical conditions that the group considered “adverse events of special interest” among 99 million vaccinated individuals in eight countries, aiming to identify higher-than-expected cases after a COVID-19 shot. The use of aggregated data increased the possibility of identifying rare safety signals that might have been missed when looking only at smaller populations.
Myocarditis, or inflammation of the heart muscle, was consistently identified following a first, second and third dose of mRNA vaccines, the study found. The highest increase in the observed-to-expected ratio was seen after a second jab with the Moderna shot. A first and fourth dose of the same vaccine was also tied to an increase in pericarditis, or inflammation of the thin sac covering the heart.
Researchers found a statistically significant increase in cases of Guillain-Barre syndrome within 42 days of an initial Oxford-developed ChAdOx1 or “Vaxzevria” shot that was not observed with mRNA vaccines. Based on the background incidence of the condition, 66 cases were expected — but 190 events were observed.
ChAdOx1 was linked to a threefold increase in cerebral venous sinus thrombosis, a type of blood clot in the brain, identified in 69 events, compared with an expected 21. The small risk led to the vaccine’s withdrawal or restriction in Denmark and multiple other countries. Myocarditis was also linked to a third dose of ChAdOx1 in some, but not all, populations studied.
Possible safety signals for transverse myelitis — spinal cord inflammation — after viral-vector vaccines was identified in the study. So was acute disseminated encephalomyelitis — inflammation and swelling in the brain and spinal cord — after both viral-vector and mRNA vaccines.
Seven cases of acute disseminated encephalomyelitis after vaccination with the Pfizer-BioNTech vaccine were observed, versus an expectation of two.
The adverse events of special interest were selected based on pre-established associations with immunization, what was already known about immune-related conditions and pre-clinical research. The study did no monitor for postural orthostatic tachycardia syndrome, or POTS, that some research has linked with COVID-19 vaccines.
Exercise intolerance, excessive fatigue, numbness and “brain fog” were among common symptoms identified in more than 240 adults experiencing chronic post-vaccination syndrome in a separate study conducted by the Yale School of Medicine. The cause of the syndrome is not yet known, and it has no diagnostic tests or proven remedies.
The Yale research aims to understand the condition to relieve the suffering of those affected and improve the safety of vaccines, said Harlan Krumholz, a principal investigator of the study, and director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation.
“Both things can be true,” Krumholz said in an interview. “They can save millions of lives, and there can be a small number of people who’ve been adversely affected.”
WAKE-UP CALL: Firms in the private sector were not taking basic precautions, despite the cyberthreats from China and Russia, a US cybersecurity official said A ninth US telecom firm has been confirmed to have been hacked as part of a sprawling Chinese espionage campaign that gave officials in Beijing access to private texts and telephone conversations of an unknown number of Americans, a top White House official said on Friday. Officials from the administration of US President Joe Biden this month said that at least eight telecommunications companies, as well as dozens of nations, had been affected by the Chinese hacking blitz known as Salt Typhoon. US Deputy National Security Adviser for Cyber and Emerging Technologies Anne Neuberger on Friday told reporters that a ninth victim
Russia and Ukraine have exchanged prisoners of war in the latest such swap that saw the release of hundreds of captives and was brokered with the help of the United Arab Emirates (UAE), officials said on Monday. Ukrainian President Volodymyr Zelenskiy said that 189 Ukrainian prisoners, including military personnel, border guards and national guards — along with two civilians — were freed. He thanked the UAE for helping negotiate the exchange. The Russian Ministry of Defense said that 150 Russian troops were freed from captivity as part of the exchange in which each side released 150 people. The reason for the discrepancy in numbers
A shark attack off Egypt’s Red Sea coast killed a tourist and injured another, authorities said on Sunday, with an Italian Ministry of Foreign Affairs source identifying both as Italian nationals. “Two foreigners were attacked by a shark in the northern Marsa Alam area, which led to the injury of one and the death of the other,” the Egyptian Ministry of Environment said in a statement. A source at the Italian foreign ministry said that the man killed was a 48-year-old resident of Rome. The injured man was 69 years old. They were both taken to hospital in Port Ghalib, about 50km north
MISSING: Prosecutors urged the company to move workers out of poor living conditions to hotels, but residents said many workers had already left the town Brazil has stopped issuing temporary work visas for BYD, the Brazilian Ministry of Foreign Affairs said on Friday, in the wake of accusations that some workers at a site owned by the Chinese electric vehicle producer had been victims of human trafficking. The announcement came days after labor authorities said they found 163 Chinese workers who had been brought to Brazil irregularly in “slavery-like” conditions at the BYD factory construction site in the northeastern state of Bahia. The workers were employed by contractor Jinjiang Group, which has denied any wrongdoing. Later, the authorities also said the workers were victims of human trafficking,
RSS